CAS 1263068-83-2

GSK 205

CAS: 1263068-83-2

Fórmula: C₂₄H₂₅BrN₄S

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 481.4511

Ref: IN-DA01ABRU

N-(4-(2-(Benzyl(MEthyl)Amino)Ethyl)Phenyl)-5-(Pyridin-3-yl)Thiazol-2-Amine Hydrobromide

CAS: 1263068-83-2

N-(4-(2-(Benzyl(MEthyl)Amino)Ethyl)Phenyl)-5-(Pyridin-3-yl)Thiazol-2-Amine Hydrobromide

Pureza: 98%

Peso molecular: 481.45g/mol

Ref: 54-OR1025912

GSK205

CAS: 1263068-83-2

GSK205

Pureza: ≥98%

Peso molecular: 481.45g/mol

Ref: 54-BUP09364

N-(4-(2-(Benzyl(methyl)amino)ethyl)phenyl)-5-(pyridin-3-yl)thiazol-2-amine hydrobromide

CAS: 1263068-83-2

Pureza: 98%

Peso molecular: 481.4599915

Ref: 10-F867689

GSK 205

CAS: 1263068-83-2

GSK 205 is a histamine receptor agonist that has been shown to have analgesic properties in animal models of pain. It binds to the TRPV4 ion channel and activates it, which results in an increase in the intracellular concentration of cations and an influx of calcium. This response has been shown to be mediated by calmodulin binding and GSK 205 also stimulates pancreatic enzyme secretion by activating the cytosolic Ca2+ response element-binding protein (CREB) pathway. The CREB pathway is involved in cell proliferation and differentiation, as well as memory formation. GSK 205 has been shown to have no adverse effects on skin cells when used at physiological levels.

Fórmula: C₂₄H₂₅BrN₄S

Pureza: Min. 95%

Peso molecular: 481.5 g/mol

Ref: 3D-NAC06883

GSK205

CAS: 1263068-83-2

GSK205 is a selective TRPV4 antagonist (IC50: 4.19 μM) for inhibiting TRPV4-mediated Ca2+ influx.

Fórmula: C₂₄H₂₅BrN₄S

Pureza: 99.46%

Cor e Forma: Solid

Peso molecular: 481.45

Ref: TM-T11480